CVR number 39715074
Industry 32.5000 Manufacture of medical and dental instruments and supplies

2R Vital ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  4.8% 3.0% 4.0% 25.3% 10.7%  
Credit score (0-100)  46 57 48 2 22  
Credit rating  BBB BBB BBB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  -1,663 -1,195 -1,400 -1,682 -2,272  
EBITDA  -1,663 -1,195 -1,400 -17,170 -2,272  
EBIT  -4,809 -4,099 -4,304 -20,074 -2,272  
Pre-tax profit (PTP)  -7,325.5 -2,904.6 -3,999.3 -19,863.6 -2,087.4  
Net earnings  -10,938.0 -2,904.6 -3,999.3 -19,863.6 -2,087.4  
Pre-tax profit without non-rec. items  -7,326 -2,905 -3,999 -19,864 -2,087  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  29,112 24,423 20,423 560 2,473  
Interest-bearing liabilities  1,023 5,600 4,600 4,000 1,150  
Balance sheet total (assets)  47,031 30,053 25,054 4,594 3,647  
Net Debt  -11,045 5,401 3,761 3,435 173  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -1,663 -1,195 -1,400 -1,682 -2,272  
Gross profit growth  0.0% 28.1% -17.1% -20.2% -35.1%  
Employees  1 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  47,031 30,053 25,054 4,594 3,647  
Balance sheet change%  0.0% -36.1% -16.6% -81.7% -20.6%  
Added value  -1,662.6 -1,195.2 -1,399.6 -17,170.4 -2,272.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  22,748 -7,502 -5,808 -21,296 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  289.2% 343.0% 307.5% 1,193.4% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -10.2% -7.1% -14.5% -134.0% -50.7%  
ROI %  -13.0% -8.2% -14.5% -134.3% -51.0%  
ROE %  -37.6% -10.9% -17.8% -189.3% -137.7%  

Solidity 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Equity ratio %  61.9% 81.3% 81.5% 12.2% 67.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  664.3% -451.9% -268.7% -20.0% -7.6%  
Gearing %  3.5% 22.9% 22.5% 714.4% 46.5%  
Net interest  0 0 0 0 0  
Financing costs %  492.2% 4.9% 0.1% 0.0% 0.0%  

Liquidity 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Quick Ratio  1.9 67.3 1.4 1.1 3.1  
Current Ratio  1.9 67.3 1.4 1.1 3.1  
Cash and cash equivalent  12,067.5 198.8 838.8 564.9 977.2  

Capital use efficiency 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  10,074.1 8,626.3 2,031.1 559.9 2,472.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/4
2021
2022/4
2022
2023/4
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -1,663 -1,195 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -1,663 -1,195 0 0 0  
EBIT / employee  -4,809 -4,099 0 0 0  
Net earnings / employee  -10,938 -2,905 0 0 0